RHHBF - Roche's setback in lung cancer trial sends anti-TIGIT developers lower
2024-07-05 07:18:27 ET
More on Roche
- Roche: Obesity Treatment's Promise Isn't Enough
- More Of The Same Isn't Good Enough For Roche
- Roche Is Joining The Obesity Party But Questions Remain
- Roche's crovalimab wins FDA approval for paroxysmal nocturnal hemoglobinuria
- Roche inks licensing pact with Ascidian for neurological diseases